Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
about
Proteomics-Based Analysis of Protein Complexes in Pluripotent Stem Cells and Cancer BiologySystems biology approaches to identify developmental bases for lung diseasesA novel classification of lung cancer into molecular subtypesReconstructing targetable pathways in lung cancer by integrating diverse omics dataDiscovering pathway cross-talks based on functional relations between pathways.Proteome analysis for downstream targets of oncogenic KRAS--the potential participation of CLIC4 in carcinogenesis in the lung.Differential reprogramming of isogenic colorectal cancer cells by distinct activating KRAS mutations.Integrating omics technologies to study pulmonary physiology and pathology at the systems level.Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.Single-step inline hydroxyapatite enrichment facilitates identification and quantitation of phosphopeptides from mass-limited proteomes with MudPITDownregulation of ubiquitin-associated protein 2-like with a short hairpin RNA inhibits human glioma cell growth in vitro.Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.The G Protein-Coupled Estrogen Receptor Agonist G-1 Inhibits Nuclear Estrogen Receptor Activity and Stimulates Novel Phosphoproteomic SignaturesSystems-wide analysis of K-Ras, Cdc42, and PAK4 signaling by quantitative phosphoproteomics.Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.Integration of proteomics into systems biology of cancer.Recent insights into human bronchial proteomics - how are we progressing and what is next?
P2860
Q26752031-380963C0-4359-40AB-A0AE-3D389C16FC98Q26824464-03258D25-290D-4091-813B-2DCA362DAC53Q28731874-64B74DCB-9936-420D-BB40-2B0AB67691D9Q30679547-9CF7C87D-D99B-4D2E-9BB6-8AC3E19C0CB4Q34530160-B94A7C94-5FF7-47D2-9BA0-E9079B884F11Q35087713-4F270D62-E089-4331-B065-E678A63D5316Q35166709-0ABDF5AA-C81B-4AE9-B4E9-04D40F25AB66Q35413415-1788925A-AFE7-4C19-925A-5A52D8851FC2Q35612406-4E2B5533-6DF0-4F15-A804-67F7546659E9Q36002714-B5534CD5-2E3E-40D9-9C11-C2905F32EF7AQ36041696-F8C85FA3-79B4-4DAF-BED8-6C6DA4BF51A3Q36273561-153464CD-F8E6-4F4D-AFC5-CC0BC1F8F437Q36386755-DACD60E0-94F0-4D35-A344-B69B8CCC6FC7Q36935460-8404E3D9-46E8-462B-8E21-7E2D2802BA01Q37072842-CB592BCC-4CE2-4D87-B00F-247105D11FA3Q37413127-4504504D-C475-47BD-A93B-F02B6785EF3EQ37992554-19A476D2-34C4-46B4-994E-FB160117542FQ47271963-F34382BD-2230-4F18-A794-164ACFFC518B
P2860
Phosphoproteomics identifies oncogenic Ras signaling targets and their involvement in lung adenocarcinomas.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@ast
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@en
type
label
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@ast
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@en
prefLabel
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@ast
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@en
P2093
P2860
P1433
P1476
Phosphoproteomics identifies o ...... ement in lung adenocarcinomas.
@en
P2093
Chia-Lang Hsu
Jeou-Yuan Chen
Mei-Jung Wang
Putty-Reddy Sudhir
Ting-Yi Sung
Ueng-Cheng Yang
Wen-Lian Hsu
Yi-Ting Wang
Yu-Ju Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0020199
P407
P577
2011-05-26T00:00:00Z